UOTTAIMCU
CHRS icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Coherus Oncology CHRS Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-41,036
Closed -$753K – 42
2020
Q3 		$753K Buy
+41,036
New +$763K 0.78% 9

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s CHRS Position: Q4 2020 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Coherus Oncology (CHRS) in Q4 2020, closing a stake of 41,036 shares — an estimated $753K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in CHRS in Q3 2020 and held it in 1 quarter. The position peaked at $753K in Q3 2020. 196 funds tracked by Wall St. Rank hold CHRS as of Q4 2020.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Coherus Oncology position as of Q4 2020 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 41,036 Coherus Oncology shares in Q4 2020, an estimated $753K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Coherus Oncology in Q3 2020 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Coherus Oncology position peaked at $753K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2020.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2020, filed 5 Feb 2021.